Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Raises Price Target for American Public Education to 15

Elaine Mendonca by Elaine Mendonca
March 6, 2024
in Breaking News
0
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

B. Riley Securities analyst Raj Sharma has reiterated his optimistic outlook on American Public Education (NASDAQ:APEI) by maintaining a Buy rating and increasing the price target to $15 from $12.

Sharma’s confidence in the company’s performance has led to this upward adjustment, indicating a positive trajectory for American Public Education as of March 6, 2024.

American Public Education, Inc. (APEI) Stock Price Decreases Slightly on March 6, 2024: What Investors Need to Know

On March 6, 2024, American Public Education, Inc. (APEI) saw a slight decrease in its stock price, closing at $11.37. This represents a drop of $0.15, or 1.30%, from the previous market close. Despite this decrease, APEI is still trading near the top of its 52-week range and above its 200-day simple moving average.

APEI is a for-profit education company that operates online learning platforms for higher education. The company offers degree programs in various fields, including business administration, education, and healthcare. With the increasing demand for online education, APEI has seen growth in its student enrollment and revenue in recent years.

The slight drop in APEI’s stock price on March 6 may be attributed to overall market fluctuations or specific factors affecting the company. Investors should consider the company’s financial performance, growth prospects, and industry trends before making any investment decisions.

American Public Education Inc. (APEI) Stock Performance Analysis on March 6, 2024

On March 6, 2024, American Public Education Inc. (APEI) stock performance was closely scrutinized by investors and analysts. The company’s total revenue for the past year stood at $606.33 million, showing a significant increase of 44.78% compared to the previous year. However, the total revenue for the third quarter was $150.84 million, which remained flat compared to the previous quarter. The net income for APEI was reported as -$114.99 million for the past year, indicating a decrease of 747.77% compared to the previous year. On the other hand, the net income for the third quarter was -$3.33 million, showing an increase of 93.5% compared to the previous quarter. Earnings per share (EPS) for APEI were reported as -$6.10 for the past year, reflecting a decrease of 727.32% compared to the previous year. However, the EPS for the third quarter was -$0.27, showing an increase of 90.71% compared to the previous quarter. Overall, APEI’s financial performance on March 6, 2024, showed mixed results. Investors and analysts closely monitored these metrics to assess the company’s financial health and future prospects.

Tags: APEI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Information Technology Stock Market Today

Analyst Maintains Neutral Rating on Cricut with Revised Price Target of 6

Finance_Budgeting (1)

B Riley Securities Analyst Reiterates Neutral Rating on LB Foster with Increased Price Target

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Analyst Reaffirms Sell Rating on Stellus Capital Investment with Lower Price Target

Recommended

iRadimed Stock

iRadimed: Record Performance Meets Divergent Institutional Strategies

7 months ago
Alphabet Stock

Alphabet Shares Under Scrutiny as CEO Pichai Executes Multi-Million Dollar Stock Sale

6 months ago
Bloom Energy Stock

Bloom Energy Shares Plunge Following Spectacular Rally

4 months ago
Strategy Stock

Strategy Shares Plunge Following Dual Capital Raise Announcement

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Hesai Group’s Milestone Profit Tempered by Cautious Guidance

Trending

Humacyte Stock
Analysis

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

by SiterGedge
March 25, 2026
0

As Humacyte prepares to release its full-year 2025 financial results, the biotechnology firm finds its stock trading...

Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Hain Celestial Stock

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline
  • MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com